ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2026

Uncoupling Type I Interferon Benefits From Inflammatory Toxicity: Transformer-Prioritized Precision Agonists for Potent and Safer Cancer Immunotherapy.

Xuefei Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.